Search Results - Matthew Lei
- Showing 1 - 3 results of 3
-
1
Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury by E. Bridget Kim, Jack E. Malespini, Matthew Lei, Samuel S. Han, Cole W. Minsky, Andrew R. Branagan, Elizabeth K. O’Donnell, Diana Cirstea, Noopur S. Raje, Andrew J. Yee
Published in Blood Advances (2025-07-01)Get full text
Article -
2
Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study by Priyanka Pullarkat, Matthew Lei, Robert Redd, Ruchi Rana, Uvette Lou, Mark Sorial, Brenna Rowen, E. Bridget Kim, Andrea Medrano, J. Erika Haydu, Jeffrey Barnes, Ephraim Hochberg, P. Connor Johnson, Ronald Takvorian, Julia Lynch, Emily Patterson, Katherine Thorp, Maryanne Sherburne, Brianne McGree, Josie Ford, Ronald Nemec, Catherine Cho, Jeremy Abramson, Jacob D. Soumerai
Published in Blood Neoplasia (2025-05-01)Get full text
Article -
3
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia by Andrew R. Branagan, Clifton Mo, Matthew Lei, Joshua N. Gustine, Andrew J. Yee, Elizabeth O’Donnell, Jorge J. Castillo, Omar Nadeem, Catherine Flynn, Zachary Bernstein, Rie Nakamoto-Matsubara, Kirsten Meid, Rakesh Verma, Zachary R. Hunter, Maria L. Guerrera, Galit Alter, Jill Burke, Cynthia Harrington, Emerentia Agyemang, Marilyn Gammon, Kathleen Lively, Lisette Packer, Nora Horick, Jacob Laubach, Constantine S. Mitsiades, Nikhil Munshi, Kenneth C. Anderson, Steven P. Treon, Paul G. Richardson, Noopur S. Raje, Shayna R. Sarosiek
Published in Blood Advances (2025-09-01)Get full text
Article
